HHS Secretary Robert F. Kennedy Jr. said he is considering a ban on government scientists publishing their work in top-tier medical journals, which he says are abed with pharmaceutical companies.
In a move that will have direct impact on approval of cancer drugs, George Francis Tidmarsh, an oncologist and a longtime pharmaceutical executive, was named director of the FDA Center for Drug Evaluation and Research.
